Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kioson Komersial Indonesia Tbk (KIOS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Kioson Komersial Indonesia TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Kioson Komersial Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kioson Komersial Indonesia Tbk trades at Rp93 (market cap 102.21B, 7.21M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Kioson Komersial Indonesia Tbk is more actively traded (7.21M versus 62.5K). Which is the better fit depends on your goals.

KIOSOBAT
Market Cap
102.21B164.65B
Volume
7.21M62.5K
Lot
72.1K625
Turnover
668.92M15.03M
Average Price
92.77240.55
Value
668.92M15.03M
Indicative Equilibrium Price
93238
Indicative Equilibrium Volume
880100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KIOS
View details
OBAT
View details

About Kioson Komersial Indonesia Tbk

PT Kioson Komersial Indonesia Tbk (the Company), was established on June 29, 2015 based on Notarial Deed No. 55 of Rose Takarina, S.H.

Read more on KIOS

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT